Biotechpharma UAB is initiating an expansion of its existing manufacturing campus in Vilnius, Lithuania. The $56 million project includes construction of a leading-edge process development lab and the installation of a new line of bioreactors for microbial fermentation at the 5,000-liter scale. Flexible facility design will also allow for increased mammalian cell culture production capacities. The expansion will enable Biotechpharma to support the full product lifecycle from upstream and downstream development and optimization to GMP manufacturing of drug substances and formulations. Completion is expected in late 2020.